Regulation of hemostatic system function by biochemical and mechanical factors

Modeling and Simulation in Science, Engineering and Technology

Volumn , Issue 9780817644109, 2007, Pages 179-210

  Rajagopal, K ^a   Lawson, J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42349093676     PISSN: 21643679     EISSN: 21643725     Source Type: Book Series    
DOI: 10.1007/978-0-8176-4411-6_5     Document Type: Chapter

References (143)

1. Altmeppen, J., Hansen, E., Bonnlander, G., Horch, R., and Jeschke, M., Composition and characteristics of an autologous thrombocyte gel. J. Surg Res., 117 (2004), 202–207.
2. Amin, T. and Sirs, J., The blood rheology of man and various animal species. Q. J. Exp. Physiol., 70 (1985), 37–49.
3. Anand, M., Rajagopal, K. and Rajagopal, K., A model incorporating some of the mechanical and biochemical factors underlying clot formation and dissolution in flowing blood. J. Theor. Med., 5 (2003).
4. Baer, P. and Cagen, L., Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam. Hypertension, 9 (1987), 253–260.
5. Berne, R. and Levy, M., Cardiovascular Physiology. Mosby, St. Louis (1992).
6. Bjork, I. and Lindahl, U., Mechanism of the anticoagulant action of heparin. Mol. Cell. Biochem., 48 (1982), 161–182.
7. Bockenstedt, P., Greenberg, J. and Handin, R., Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor. J. Clin. Invest., 77 (1986), 743–749.
8. Bontempo, F., Lewis, J., Gorenc, T., Spero, J., Ragni, M., Scott, J. and Starzl, T., Liver transplantation in hemophilia A. Blood, 69 (1987), 1721–1724.
9. Boyle Kay, M. and Fudenberg, H., Inhibition and reversal of platelet activation by cytochalasin B or colcemid. Nature, 244 (1973), 288–289.
10. Broze, G.J. and Majerus, P., Purification and properties of human coagulation factor VII. J. Biol. Chem., 255 (1980), 1242–1247.
11. Broze, G.J., Warren, L., Novotny, W., Higuchi, D., Girard, J. and Miletich, J., The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood, 71 (1988), 335–343.
12. Cadroy, Y. and Hanson, S., Effects of red blood cell concentration on hemostasis and thrombus formation in a primate model. Blood, 75 (1990), 2185–2193.
13. Carr, M. and Powers, P., Differential effects of divalent cations on fibrin structure. Blood Coagul. Fibrinolysis, 2 (1991), 741–747.
14. Chien, S., Usami, S., Taylor, H., Lundberg, J. and Gregersen, M., Effects of hematocrit and plasma proteins on human blood rheology at low shear rates. J. Appl. Physiol., 21 (1966), 81–87.
15. Cines, D., Pollak, E., Buck, C., Loscalzo, J., Zimmerman, G., McEver, R., Pober, J., Wick, T., Konkle, B., Schwartz, B., et al., Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 91 (1998), 3527–3561.
16. Clemetson, K., Platelet activation: Signal transduction via membrane receptors. Thromb. Haemost., 74 (1995), 111–116.
17. Collen, D. and Lijnen, H., Fibrin-specific fibrinolysis. Ann. N.Y. Acad. Sci., 667 (1992), 259–271.
18. Collet, J., Shuman, H., Ledger, R., Lee, S. and Weisel, J., The elasticity of an individual fibrin fiber in a clot. Proc. Natl. Acad. Sci. USA, 102 (2005), 9133–9137.
19. Cruz, M., Chen, J., Whitelock, J., Morales, L. and Lopez, J., The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor alpha2beta1 to bind collagen: Activationdependent conformational change of the alpha2-I domain. Blood, 105 (2005), 1986–1991.
20. Czapiga, M., Gao, J., Kirk, A. and Lekstrom-Himes, J., Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp. Hematol., 33 (2004), 73–84.
21. De Marco, L., Perris, R., Cozzi, M. and Mazzucato, M., Blood clotting in space. J. Biol. Regul. Homeost. Agents, 18 (2004), 187–192.
22. de Vries, C., Veerman, H., Blasi, F. and Pannekoek, H., Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): A comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins. Biochemistry, 27 (1988), 2565–2572.
23. Desai, U., Petitou, M., Bjork, I. and Olson, S., Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin. J. Biol. Chem., 273 (1998), 7478–7487.
24. Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J., Morelli, A., Torboli, M., Bolognesi, G. and Baricordi, O., Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood, 97 (2001), 587–600.
25. Diamond, S., Eskin, S. and McIntire, L., Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science, 243 (1989), 1483–1485.
26. Do, H., Healey, J., Waller, E. and Lollar, P., Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol. Chem., 274 (1999), 19587–19592.
27. Doerschuk, C., Downey, G., Doherty, D., English, D., Gie, R., Ohgami, M., Worthen, G., Henson, P. and Hogg, J., Leukocyte and platelet margination within microvasculature of rabbit lungs. J. Appl. Physiol., 68 (1990), 1956–1961.
28. Dong, J., Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J. Thromb. Haemost., 3 (2005), 1710–1716.
29. Ernst, E., The non Newtonian properties of plasma. Haematologica, 67 (1982), 321–322.
30. Esmon, C., Owen, W. and Jackson, C., A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid, and calcium ions. J. Biol. Chem., 249 (1974), 8045–8047.
31. Esmon, N., Owen, W. and Esmon, C., Isolation of a membranebound cofactor for thrombin-catalyzed activation of protein C. J. Biol. Chem., 257 (1982), 859–864.
32. Evans, E. and La Celle, P., Intrinsic material properties of the erythrocyte membrane indicated by mechanical analysis of deformation. Blood, 45 (1975), 29–43.
33. Falati, S., Gross, P., Merrill-Skoloff, G., Furie, B. and Furie, B., Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat. Med., 8 (2002), 1175–1181.
34. Figures, W., Scearce, L., Wachtfogel, Y., Chen, J., Colman, R. and Colman, R., Platelet ADP receptor and alpha 2-adrenoreceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding. J. Biol. Chem., 261 (1986), 5981–5986.
35. Freedman, J., Frei, B., Welch, G. and Loscalzo, J., Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J. Clin. Invest., 96 (1995), 394–400.
36. Furie, B. and Furie, B., Thrombus formation in vivo. J. Clin. Invest., 115 (2005), 3355–3362.
37. Furlan, M., Von Willebrand factor: Molecular size and functional activity. Ann. Hematol., 72 (1996), 341–348.
38. Furman, M., Gardner, T. and Goldschmidt-Clermont, P., Mechanisms of cytoskeletal reorganization during platelet activation. Thromb. Haemost., 70 (1993), 229–232.
39. Gambillara, V., Chambaz, C., Roy, S., Stergiopulos, N. and Silacci, P., Plaque-prone hemodynamic impairs endothelial function in pig carotid arteries. Am. J. Physiol. Heart Circ. Physiol. (2006) epub:epub.
40. George, J., el-Harake, M. and Raskob, G., Chronic idiopathic thrombocytopenic purpura. New Engl. J. Med., 331 (1994), 1207–1211.
41. Gerth, C., Roberts, W. and Ferry, J., Rheology of fibrin clots. II. Linear viscoelastic behavior in shear creep. Biophys. Chem., 2 (1974), 208–217.
42. Giddings, J., Jarvis, A. and Hogg, S., Factor V in human vascular endothelium and in endothelial cells in culture. Thromb. Res., 44 (1986), 829–835.
43. Giraux, J., Tapon-Bretaudiere, J., Matou, S. and Fischer, A., Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells. Thromb. Haemost., 80 (1998), 692–695.
44. Grabowski, E. and Lam, F., Endothelial cell function, including tissue factor expression, under flow conditions. Thromb. Haemost., 74 (1995), 123–128.
45. Graff, J., Klinkhardt, U. and Harder, S., Pharmacodynamic profile of antiplatelet agents: Marked differences between single versus costimulation with platelet activators. Thromb. Res., 113 (2004), 295–302.
46. Griffin, J. and Cochrane, C., Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc. Natl. Acad. Sci. USA, 73 (1976), 2554–2558.
47. Hagen, I. and Solum, N., Further studies on the protein composition and surface structure of normal platelets and platelets from patients with Glanzmann’s thrombasthenia and Bernard-Soulier syndrome. Thromb. Res., 13 (1978), 845–855.
48. Hagen, I., Brosstad, F., Gogstad, G., Korsmo, R. and Solum, N., Further studies on the interaction between thrombin and GP Ib using crossed immunoelectrophoresis. Effect of thrombin inhibitors. Thromb. Res., 27 (1982), 549–554.
49. Hamilton, J., Nguyen, P. and Cocks, T., Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries. Circ. Res., 82 (1998), 1306–1311.
50. Hashimoto, S., Maeda, H. and Sasada, T., Effect of shear rate on clot growth at foreign surfaces. Artif. Organs, 9 (1985), 345–350.
51. Haynes, R. and Burton, A., Role of the non-Newtonian behavior of blood in hemodynamics. Am. J. Physiol., 197 (1959), 943–950.
52. Henderson, N. and Thurston, G., A new method for the analysis of blood and plasma coagulation. Biomed. Sci. Instrum., 29 (1993), 95–102.
53. Higashi, S., Matsumoto, N. and Iwanaga, S., Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity. J. Biol. Chem., 271 (1996), 26569–26574.
54. Hojima, Y., Cochrane, C., Wiggins, R., Austen, K. and Stevens, R., In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Blood, 63 (1984), 1453–1459.
55. Hollopeter, G., Jantzen, H., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R., Nurden, P., Nurden, A., Julius, D., et al., Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature, 409 (2001), 202–207.
56. Hyman, A., Chapnick, B., Kadowitz, P., Lands, W., Crawford, C., Fried, J. and Barton, J., Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids. Proc. Natl. Acad. Sci. USA, 74 (1977), 5411–5415.
57. Ignarro, L., Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J. Physiol. Pharmacol., 53 (2002), 503–514.
58. Investigators, T.P.T., Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. New Engl. J. Med., 339 (1998), 436–443.
59. Issekutz, A. and Ripley, M., The effect of intravascular neutrophil chemotactic factors on blood neutrophil and platelet kinetics. Am. J. Hematol., 21 (1986), 157–171.
60. Janmey, P., Amis, E. and Ferry, J., Rheology of fibrin clots. VI. Stress relaxation, creep, and differential dynamic modulus of fine clots. J. Rheol., 27 (1983), 135–153.
61. Jesty, J. and Nemerson, Y., Purification of Factor VII from bovine plasma. Reaction with tissue factor and activation of Factor X. J. Biol. Chem., 249 (1974), 509–515.
62. Jones, K. and Mann, K., A model for the tissue factor pathway to thrombin. II. A mathematical simulation. J. Biol. Chem., 269 (1994), 23367–23373.
63. Kalafatis, M., Egan, J., van ’t Veer, C., Cawthern, K. and Mann, K., The regulation of clotting factors. Crit. Rev. Eukaryot. Gene Expr., 7 (1997), 241–280.
64. Kanaide, H. and Shainoff, J., Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa). J. Lab. Clin. Med., 85 (1975), 574–597.
65. Karino, T. and Motomiya, M., Flow through a venous valve and its implication for thrombus formation. Thromb. Res., 36 (1984), 245–257.
66. Khirabadi, B., Foegh, M., Goldstein, H. and Ramwell, P., The effect of prednisolone, thromboxane, and platelet-activating factor receptor antagonists on lymphocyte and platelet migration in experimental cardiac transplantation. Transplantation, 43 (1987), 626–630.
67. Kirchhofer, D., Eigenbrot, C., Lipari, M., Moran, P., Peek, M. and Kelley, R., The tissue factor region that interacts with factor Xa in the activation of factor VII. Biochemistry, 40 (2001), 675–682.
68. Kleinstreuer, C., Hyun, S., Buchanan, J.J., Longest, P., Archie, J.J. and Truskey, G., Hemodynamic parameters and early intimal thickening in branching blood vessels. Crit. Rev. Biomed. Eng., 29 (2001), 1–64.
69. Ku, D., Giddens, D., Zarins, C. and Glagov, S., Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis, 5 (1985), 293–302.
70. Kuharsky, A. and Fogelson, A., Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys. J., 80 (2001), 1050–1074.
71. Laki, K., The action of thrombin on fibrinogen. Science, 114 (1951), 435–436.
72. Lawson, J. and Mann, K., Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J. Biol. Chem., 266 (1991), 11317–11327.
73. Lee, E. and Schiffer, C., Evidence for rapid mobilization of platelets from the spleen during intensive plateletpheresis. Am. J. Hematol., 19 (1985), 161–165.
74. Lefkovits, J., Plow, E. and Topol, E., Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. New Engl. J. Med., 332 (1995), 1553–1559.
75. Lopes, A., Maeda, N., Aiello, V., Ebaid, M. and Bydlowski, S., Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension. Chest, 104 (1993), 1455–1460.
76. Lou, Z., Yang, W. and Stein, P., Errors in the estimation of arterial wall shear rates that result from curve fitting of velocity profiles. J. Biomech., 26 (1993), 383–390.
77. Lowenhaupt, R., Silberstein, E., Sperling, M. and Mayfield, G., A quantitative method to measure human platelet chemotaxis using indium-111-oxine-labeled gel-filtered platelets. Blood, 60 (1982), 1345–1352.
78. Lutz, R., Cannon, J., Bischoff, K., Dedrick, R., Stiles, R. and Fry, D., Wall shear stress distribution in a model canine artery during steady flow. Circ. Res., 41 (1977), 391–399.
79. Maalej, N., Holden, J. and Folts, J., Effect of shear stress on acute platelet thrombus formation in canine stenosed carotid arteries: An in vivo quantitative study. J. Thromb. Thrombolysis, 5 (1998), 231–238.
80. Mann, K., Deutsch, S., Tarbell, J., Geselowitz, D., Rosenberg, G. and Pierce, W.S., An experimental study of Newtonian and non- Newtonian flow dynamics in a ventricular assist device. J. Biomech. Eng., 109 (1987), 139–147.
81. Markel, A., Manzo, R., Bergelin, R. and Strandness, D.J., Pattern and distribution of thrombi in acute venous thrombosis. Arch. Ann. 127 (1992), 305–309.
82. Markle, D., Evans, E. and Hochmuth, R., Force relaxation and permanent deformation of erythrocyte membrane. Biophys. J., 42 (1983), 91–98.
83. Mattler, L. and Bang, N., Serine protease specificity for peptide chromogenic substrates. Thromb. Haemost., 38 (1977), 776–792.
84. Menoud, P., Sappino, N., Boudal-Khoshbeen, M., Vassalli, J. and Sappino, A., The kidney is a major site of alpha(2)-antiplasmin production. J. Clin. Invest., 97 (1996), 2478–2484.
85. Merrill, E. and Pelletier, G., Viscosity of human blood: Transition from Newtonian to non-Newtonian. J. Appl. Physiol., 23 (1967), 178–182.
86. Merten, M., Pakala, R., Thiagarajan, P. and Benedict, C., Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation, 99 (1999), 2577–2582.
87. Misra, J. and Choudhury, K., Effect of initial stresses on the wave propagation in arteries. J. Math. Biol., 18 (1983), 53–67.
88. Mo, L., Yip, G., Cobbold, R., Gutt, C., Joy, M., Santyr, G. and Shung, K., Non-Newtonian behavior of whole blood in a large diameter tube. Biorheology, 28 (1991), 421–427.
89. Moore, J.J., Ku, D., Zarins, C. and Glagov, S., Pulsatile flow visualization in the abdominal aorta under differing physiologic conditions: implications for increased susceptibility to atherosclerosis. J. Biomech. Eng., 114 (1992), 391–397.
90. Morris, C., Smith, C.N. and Blackshear, P.J., A new method for measuring the yield stress in thin layers of sedimenting blood. Biophys. J., 52 (1987), 229–240.
91. Murata, T. and Secomb, T., Effects of shear rate on rouleau formation in simple shear flow. Biorheology, 25 (1988), 113–122.
92. Mustard, J., Perry, D., Kinlough-Rathbone, R. and Packham, M., Factors responsible for ADP-induced release reaction of human platelets. Am. J. Physiol., 228 (1975), 1757–1765.
93. Nachman, R. and Leung, L., Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J. Clin. Invest., 69 (1982), 263–269.
94. Nelb, G., Gerth, C., Ferry, J. and Lorand, L., Rheology of fibrin clots. III. Shear creep and creep recovery of fine ligated and coarse unligated clots. Biophys. Chem., 5 (1976), 377–387.
95. Nelb, G., Kamykowski, G. and Ferry, J., Rheology of fibrin clots. V. shear modulus, creep, and creep recovery of fine unligated clots. Biophys. Chem., 13 (1981), 15–23.
96. Olson, S., Swanson, R., Raub-Segall, E., Bedsted, T., Sadri, M., Petitou, M., Herault, J., Herbert, J. and Bjork, I., Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. Thromb. Haemost., 92 (2004), 929–939.
97. Olson, T., Singbartl, K. and Ley, K., L-selectin is required for fMLPbut not C5a-induced margination of neutrophils in pulmonary circulation. Am. J. Physiol. Regul. Integr. Comp. Physiol., 282 (2002), R1245–R1252.
98. Osterud, B., Factor VII and haemostasis. Blood Coagul. Fibrinolysis, 1 (1990), 175–181.
99. Osterud, B., Laake, K. and Prydz, H., The activation of human factor IX. Thromb. Diath. Haemorrh., 33 (1975), 553–563.
100. Parry, G. and Mackman, N., Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler. Thromb. Vasc. Biol., 15 (1995), 612–621.
101. Patel, S., Hartwig, J. and Italiano, J.J., The biogenesis of platelets from megakaryocyte proplatelets. J. Clin. Invest., 115 (2005), 3348–3354.
102. Pieters, J., Lindhout, T. and Hemker, H., In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. Blood, 74 (1989), 1021–1024.
103. Prosi, M., Perktold, K., Ding, Z. and Friedman, M., Influence of curvature dynamics on pulsatile coronary artery flow in a realistic bifurcation model. J. Biomech., 37 (2004), 1767–1775.
104. Rajagopal, K., Lefkowitz, R. and Rockman, H., When 7 transmembrane receptors are not G protein-coupled receptors. J. Clin. Invest., 115 (2005), 2971–2974.
105. Ramaswamy, S., Vigmostad, S., Wahle, A., Lai, Y., Olszewski, M., Braddy, K., Brennan, T., Rossen, J., Sonka, M. and Chandran, K., Comparison of left anterior descending coronary artery hemodynamics before and after angioplasty. J. Biomech. Eng., 128 (2006), 40–48.
106. Rendu, F. and Brohard-Bohn, B., The platelet release reaction: Granules’ constituents, secretion and functions. Platelets, 12 (2001), 261–273.
107. Riha, P., Wang, X., Liao, R. and Stoltz, J., Elasticity and fracture strain of whole blood clots. Clin. Hemorheol. Microcirc., 21 (1999), 45–49.
108. Rockman, H., Koch, W. and Lefkowitz, R. Seven-transmembranespanning receptors and heart function. Nature, 415 (2002), 206–212.
109. Rosenberg, J., Foster, P., Kaufman, R., Vokac, E., Moussalli, M., Kroner, P. and Montgomery, R., Intracellular trafficking of factor VIII to von Willebrand factor storage granules. J. Clin. Invest., 101 (1998), 613–624.
110. Ruggeri, Z., De Marco, L., Gatti, L., Bader, R. and Montgomery, R., Platelets have more than one binding site for von Willebrand factor. J. Clin. Invest., 72 (1983), 1–12.
111. Runyon, M., Johnson-Kerner, B. and Ismagilov, R.F., Minimal functional model of hemostasis in a biomimetic microfluidic system. Angew Chem. Int. Ed. Engl., 43 (2004), 1531–1536.
112. Sadler, J., von Willebrand factor: Two sides of a coin. J. Thromb. Haemost., 3 (2005), 1702–1709.
113. Sadowski, J., Esmon, C. and Suttie, J., Vitamin K-dependent carboxylase. Requirements of the rat liver microsomal enzyme system. J. Biol. Chem., 251 (1976), 2770–2776.
114. Salem, H., Broze, G., Miletich, J. and Majerus, P., Human coagulation factor Va is a cofactor for the activation of protein C. Proc. Natl. Acad. Sci. USA, 80 (1983), 1584–1588.
115. Savi, P. and Herbert, J., Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin. Thromb. Hemost., 31 (2005), 174–183.
116. Schaffner, A., Augustiny, N., Otto, R. and Fehr, J., The hypersplenic spleen. A contractile reservoir of granulocytes and platelets. Arch. Int. Med., 145 (1985), 651–654.
117. Schmid-Schonbein, G., Usami, S., Skalak, R. and Chien, S., The interaction of leukocytes and erythrocytes in capillary and postcapillary vessels. Microvasc. Res., 19 (1980), 45–70.
118. Schmid-Schonbein, H., Gallasch, G., von Gosen, J., Volger, E. and Klose, H., Red cell aggregation in blood flow. I. New methods of quantification. Klin. Wochenschr., 54 (1976), 149–157.
119. Schuster, J. and Nelson, P., Toll receptors: An expanding role in our understanding of human disease. J. Leukoc. Biol., 67 (2000), 767–773.
120. Shapira, N., Schaff, H., White, R. and Pluth, J., Hemodynamic effects of calcium chloride injection following cardiopulmonary bypass: response to bolus injection and continuous infusion. Ann. Thor. Ann., 37 (1984), 133–140.
121. Sherry, S., Fibrinolysis. Ann. Rev. Med., 19 (1968), 247–268.
122. Shimaoka, M. and Springer, T., Therapeutic antagonists and conformational regulation of integrin function. Nat. Rev. Drug Discov., 2 (2003), 703–716.
123. Shulman, S., Herwig, W. and Ferry, J., The conversion of fibrinogen to fibrin. V. Influence of ionic strength and thrombin concentration on the effectiveness of certain reversible inhibitors. Arch. Biochem., 32 (1951), 354–358.
124. Sjogren, L., Doroudi, R., Gan, L., Jungersten, L., Hrafnkelsdottir, T. and Jern, S., Elevated intraluminal pressure inhibits vascular tissue plasminogen activator secretion and downregulates its gene expression. Hypertension, 35 (2000), 1002–1008.
125. Sperry, J., Deming, C., Bian, C., Walinsky, P., Kass, D., Kolodgie, F., Virmani, R., Kim, A. and Rade, J., Wall tension is a potent negative regulator of in vivo thrombomodulin expression. Circ. Res., 92 (2003), 41–47.
126. Stern, D., Drillings, M., Kisiel, W., Nawroth, P., Nossel, H. and LaGamma, K., Activation of factor IX bound to cultured bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA, 81 (1984), 913–917.
127. Telesforo, P., Semeraro, N., Verstraete, M. and Collen, D., The inhibition of plasmin by antithrombin III-heparin complex in vitro in human plasma and during streptokinase therapy in man. Thromb. Res., 7 (1975), 669–676.
128. Thurston, G., Viscoelasticity of human blood. Biophys. J., 12 (1972), 1205–1217.
129. Thurston, G. and Henderson, N., Impedance of a fibrin clot in a cylindrical tube: Relation to clot permeability and viscoelasticity. Biorheology, 32 (1995), 503–520.
130. Tsai, H., Sussman, I. and Nagel, R., Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood, 83 (1994), 2171–2179.
131. van Dieijen, G., Tans, G., Rosing, J. and Hemker, H., The role of phospholipid and factor VIIIa in the activation of bovine factor X. J. Biol. Chem., 256 (1981), 3433–3442.
132. Virchow, R. Uber den Fasenstoff: V. phlogose und thrombose im gefabsystem. In Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Verlag v. Meidinger, Sohn and Corp., Frankfurt am Main (1856).
133. Wang, J. and Thampatty, B., An introductory review of cell mechanobiology. Biomech. Model Mechanobiol., 5 (2006), 1–16.
134. Warn-Cramer, B., Almus, F. and Rapaport, S., Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells. Thromb. Haemost., 61 (1989), 101–105.
135. Wells, D., Archie, J.J. and Kleinstreuer, C., Effect of carotid artery geometry on the magnitude and distribution of wall shear stress gradients. J. Vasc. Ann., 23 (1996), 667–678.
136. Wissler, R., Update on the pathogenesis of atherosclerosis. Am. J. Med., 91 (1991), 3S-9S.
137. Wootton, D. and Ku, D., Fluid mechanics of vascular systems, diseases, and thrombosis. Annu. Rev. Biomed. Eng., 1 (1999), 299–329.
138. Xiao, T., Takagi, J., Coller, B., Wang, J. and Springer, T. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature, 432 (2004), 59–67.
139. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki, T., A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332 (1988), 411–415.
140. Yasuda, T., Sekimoto, K., Taga, I., Funakubo, A., Fukui, Y. and Takatani, S., New method for the detection of thrombus formation in cardiovascular devices: Optical sensor evaluation in a flow chamber model. ASAIO J., 51 (2005), 110–115.
141. Yeh, C., Wang, W., Hsieh, T. and Huang, T., Agkistin, a snake venom-derived glycoprotein Ib antagonist, disrupts von Willebrand factor-endothelial cell interaction and inhibits angiogenesis. J. Biol. Chem., 275 (2000), 18615–18618.
142. Yeleswarapu, K., Antaki, J., Kameneva, M. and Rajagopal, K., A mathematical model for shear-induced hemolysis. Artif. Organs, 19 (1995), 576–582.
143. Zarins, C., Giddens, D., Bharadvaj, B., Sottiurai, V., Mabon, R. and Glagov, S., Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ. Res., 53 (1983), 502–514.